WallStreetZenWallStreetZen

NASDAQ: LTRN
Lantern Pharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lantern Pharma earnings were -$18.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LTRN earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$7.1M, up 112.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LTRN reported annual earnings of -$17.1M, with -17.6% growth.

LTRN earnings history

Current Revenue
$0.0
Current Earnings
-$18.7M
Current Profit Margin
0%

LTRN Return on Equity

Current Company
-456.4%
Current Industry
-13.7%
Current Market
29%
LTRN's Return on Equity (-456.4%)... subscribe to Premium to read more.
High Return on Equity Performance

LTRN Return on Assets

Current Company
-184.3%
Current Industry
-10.4%
LTRN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LTRN announces earnings.

LTRN Return on Capital Employed

Current Company
-435.83%
Current Industry
-6.8%
LTRN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LTRN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LTRN-$18.51M-$18.65MN/A-$1.62
BYSI-$6.38M-$6.69MN/A-$0.16
GNTA-$7.47M-$7.51MN/A-$0.38
KYNB$192.70M$183.19MN/A$45.28
ACTU-$20.43M-$20.45MN/A-$0.87
View Top Biotech Stocks

Lantern Pharma Earnings Reports & History FAQ

What were Lantern Pharma's earnings last quarter?

On LTRN's earnings call on Aug 14, 2026, Lantern Pharma (NASDAQ: LTRN) reported Q2 2026 earnings per share (EPS) of -$0.57, up 42.5% year over year. Total LTRN earnings for the quarter were -$7.07 million. In the same quarter last year, Lantern Pharma's earnings per share (EPS) was -$0.40.

If you're new to stock investing, here's how to buy Lantern Pharma stock.

Is Lantern Pharma profitable or losing money?

As of the last Lantern Pharma earnings report, Lantern Pharma is currently losing money. Lantern Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$18.65 million, a 3.1% decrease year over year.

What was LTRN's earnings growth in the past year?

As of Lantern Pharma's earnings date in Aug 14, 2026, Lantern Pharma's earnings has grown year over year. LTRN earnings in the past year totalled -$18.65 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.